Idorsia Valuation

IDIA Stock  CHF 1.00  0.07  6.54%   
Today, the firm appears to be overvalued. Idorsia retains a regular Real Value of ₣0.96 per share. The prevalent price of the firm is ₣1.0. Our model calculates the value of Idorsia from evaluating the firm fundamentals such as Return On Equity of -64.61, return on asset of -0.42, and Shares Outstanding of 187.56 M as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
1.00
Please note that Idorsia's price fluctuation is abnormally volatile at this time. Calculation of the real value of Idorsia is based on 3 months time horizon. Increasing Idorsia's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Idorsia stock is determined by what a typical buyer is willing to pay for full or partial control of Idorsia. Since Idorsia is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Idorsia Stock. However, Idorsia's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  1.0 Real  0.96 Hype  1.07 Naive  1.1
The intrinsic value of Idorsia's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Idorsia's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
0.96
Real Value
6.60
Upside
Estimating the potential upside or downside of Idorsia helps investors to forecast how Idorsia stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Idorsia more accurately as focusing exclusively on Idorsia's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.790.901.01
Details
Hype
Prediction
LowEstimatedHigh
0.051.076.71
Details
Naive
Forecast
LowNext ValueHigh
0.021.106.74
Details

Idorsia Total Value Analysis

Idorsia is currently anticipated to have takeover price of 2.88 B with market capitalization of 2.31 B, debt of 1.13 B, and cash on hands of 811.85 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Idorsia fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
2.88 B
2.31 B
1.13 B
811.85 M

Idorsia Investor Information

About 36.0% of the company shares are held by company insiders. The company recorded a loss per share of 4.26. Idorsia last dividend was issued on the 16th of June 2017. The entity had 1585:1564 split on the 13th of October 2020. Based on the key measurements obtained from Idorsia's financial statements, Idorsia is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.

Idorsia Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Idorsia has an asset utilization ratio of 10.74 percent. This indicates that the Company is making ₣0.11 for each dollar of assets. An increasing asset utilization means that Idorsia is more efficient with each dollar of assets it utilizes for everyday operations.

Idorsia Ownership Allocation

Idorsia has a total of 187.56 Million outstanding shares. Idorsia secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Idorsia Profitability Analysis

The company reported the revenue of 97.1 M. Net Loss for the year was (827.9 M) with loss before overhead, payroll, taxes, and interest of (292.5 M).

About Idorsia Valuation

Our relative valuation model uses a comparative analysis of Idorsia. We calculate exposure to Idorsia's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Idorsia's related companies.
Idorsia Ltd, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs. The company was incorporated in 2017 and is headquartered in Allschwil, Switzerland. Idorsia Ltd is traded on Switzerland Exchange in Switzerland.

8 Steps to conduct Idorsia's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Idorsia's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Idorsia's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Idorsia's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Idorsia's revenue streams: Identify Idorsia's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Idorsia's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Idorsia's growth potential: Evaluate Idorsia's management, business model, and growth potential.
  • Determine Idorsia's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Idorsia's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Additional Tools for Idorsia Stock Analysis

When running Idorsia's price analysis, check to measure Idorsia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Idorsia is operating at the current time. Most of Idorsia's value examination focuses on studying past and present price action to predict the probability of Idorsia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Idorsia's price. Additionally, you may evaluate how the addition of Idorsia to your portfolios can decrease your overall portfolio volatility.